(Q53234196)

English

Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Wettstein A

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

393-401

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential validity of psychometric tests in dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Factor structure and scoring of the SKT test battery.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980066-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0944-7113(00)80066-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10755847%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53234196&oldid=1611085544"